HANGZHOU SOLIPHARMA CO LTD has a total of 16 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and materials and metallurgy are JIANGSU JIBEIER PHARMACEUTICAL CO LTD, XCOVERY HOLDINGS INC and PAION UK LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | China | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Materials and metallurgy |
# | Name | Total Patents |
---|---|---|
#1 | Sheng Xiaoxia | 16 |
#2 | Sheng Xiaohong | 14 |
#3 | Tang Yong | 2 |
#4 | Zhu Tao | 2 |
#5 | Dai Yanli | 1 |
#6 | Zheng Jianfeng | 1 |
#7 | Zhao Kun | 1 |
#8 | Wang Jing | 1 |
#9 | Chen Jian | 1 |
#10 | Jiang Xiawei | 1 |
Publication | Filing date | Title |
---|---|---|
CN111801323A | Crystal form of bemaciclib mesylate, preparation method and pharmaceutical composition thereof | |
CN111868054A | Furosetinib eutectic crystal, preparation method, composition and application thereof | |
US2019248788A1 | ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereof |